Elevations in the Lp(a) level occur in CKD patients vs. controls in a size-specific manner, i.e., larger, but not smaller, apo(a) isoforms are associated with 2- to 4-fold higher Lp(a) levels in CKD patients compared to isoform-matched healthy controls [24,25]. This evidence concerns the gene LPA and chronic kidney disease.